Cav2.1 Voltage-dependent Ca2+ Channel Current is Inhibited by Serum from Select Patients with Guillain-Barré Syndrome.

MLA

Sayako Hotta, et al. “Cav2.1 Voltage-Dependent Ca2+ Channel Current Is Inhibited by Serum from Select Patients with Guillain-Barré Syndrome.” Neurochemical Research, vol. 34, no. 1, Jan. 2009, pp. 149–57. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=36040017&authtype=sso&custid=ns315887.

APA

Sayako Hotta, Iku Utsunomiya, Keiko Tanaka, Keiko Hoshi, Toshi Ariga, Robert Yu, Tadashi Miyatake, & Kyoji Taguchi. (2009). Cav2.1 Voltage-dependent Ca2+ Channel Current is Inhibited by Serum from Select Patients with Guillain-Barré Syndrome. Neurochemical Research, 34(1), 149–157.

Chicago

Sayako Hotta, Iku Utsunomiya, Keiko Tanaka, Keiko Hoshi, Toshi Ariga, Robert Yu, Tadashi Miyatake, and Kyoji Taguchi. 2009. “Cav2.1 Voltage-Dependent Ca2+ Channel Current Is Inhibited by Serum from Select Patients with Guillain-Barré Syndrome.” Neurochemical Research 34 (1): 149–57. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=36040017&authtype=sso&custid=ns315887.